Daniel Weiner - Simulations Plus Director


USD 41.88  0.42  1.01%   

Dr. Daniel L. Weiner is Director of the company. He has extensive drug development experience and has served as an expert consultant to the U.S. Food and Drug Administration on pharmacokinetic modeling and bioequivalence assessment. Prior to his previous tenure with CertaraPharsight as a Senior Vice President and Chief Science Officer, Dr. Weiner held several management positions with Merrell Dow Pharmaceuticals Statistical Consultants, Inc. Syntex Development Research Quintiles and IVAX Research. Dr. Weiner graduated from the University of Kentucky with a doctoral degree in Mathematical Statistics, with emphasis on compartmental modeling. He is the original designerauthor of the WinNonlin family of PKPD Modeling Software now used by over 1, 000 institutions. He is the coauthor of Pharmacokinetic and Pharmacodynamic Data Analysis Concepts and Applications, now in its fifth edition. Dr. Weiner is an Adjunct Associate Professor with the Division of Pharmacotherapy and Experimental Therapeutics in the School of Pharmacy, University of North Carolina, and an Affiliate Professor of Pharmacometrics, Center for Translational Medicine in the School of Pharmacy at the University of Maryland.
Age: 66  Director Since 2017      
661 723 7723  https://www.simulations-plus.com

Simulations Plus Management Efficiency

Simulations Plus has Return on Asset of 0.0506 % which means that on every $100 spent on asset, it made $0.0506 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.0726 %, implying that it generated $0.0726 on every 100 dollars invested. Simulations Plus management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Simulations Plus Return on Investment is very stable at the moment as compared to the past year. Simulations Plus reported last year Return on Investment of 8.67. As of 2nd of December 2022, Return on Average Assets is likely to grow to 6.96, while Return on Invested Capital is likely to drop 1.42. Simulations Plus Current Liabilities is very stable at the moment as compared to the past year. Simulations Plus reported last year Current Liabilities of 7.74 Million. As of 2nd of December 2022, Liabilities Non Current is likely to grow to about 4 M, while Total Liabilities is likely to drop about 8.4 M.
The company has 1.53 M in debt with debt to equity (D/E) ratio of 0.01, which may show that the company is not taking advantage of profits from borrowing. Simulations Plus has a current ratio of 24.0, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Simulations Plus until it has trouble settling it off, either with new capital or with free cash flow. So, Simulations Plus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Simulations Plus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Simulations to invest in growth at high rates of return. When we think about Simulations Plus' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives


Gabriel VenturaAnheuser Busch Inbev
William GiffordAnheuser Busch Inbev
Mariusz JamkaAnheuser Busch Inbev
Paulo LemannAnheuser Busch Inbev
Alexandre BehringAnheuser Busch Inbev
Mark WinkelmanAnheuser Busch Inbev
Suma PrasadAnheuser Busch Inbev
Alejandro DomingoAnheuser Busch Inbev
Gregoire SpoelberchAnheuser Busch Inbev
Xiaozhi LiuAnheuser Busch Inbev
Maria AramburuzabalaAnheuser Busch Inbev
Paul RuartAnheuser Busch Inbev
Olivier GoudetAnheuser Busch Inbev
Michele BurnsAnheuser Busch Inbev
Alexandre DammeAnheuser Busch Inbev
Cecilia SicupiraAnheuser Busch Inbev
Stefan DescheemaekerAnheuser Busch Inbev
Carlos SicupiraAnheuser Busch Inbev
Kasper RorstedAnheuser Busch Inbev
Marcel TellesAnheuser Busch Inbev
Elio ScetiAnheuser Busch Inbev
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Simulations Plus is traded on NASDAQ Exchange in the United States. Simulations Plus (SLP) is traded on NASDAQ Exchange in USA and employs 157 people. Simulations Plus is listed under Health Care Technology category by Fama And French industry classification.

Simulations Plus Leadership Team

Elected by the shareholders, the Simulations Plus' board of directors comprises two types of representatives: Simulations Plus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Simulations. The board's role is to monitor Simulations Plus' management team and ensure that shareholders' interests are well served. Simulations Plus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Simulations Plus' outside directors are responsible for providing unbiased perspectives on the board's policies.
Brett Howell, Inc Services
MS MAS, CoFounder Chairman
MS MS, Pres Division
John DiBella, Vice President - Sales & Marketing
David DArgenio, Independent Director
Viera Lukacova, Chief Officer
Thaddeus Grasela, Director
Shawn OConnor, Chief Officer
John Kneisel, CFO
Lisa LaVange, Director
Lindsay Luke, Ex HR
Walter Woltosz, Co-Founder, Chairman and CEO
John Paglia, Director
Bud JD, VP Officer
John MS, President
Arlene Padron, Co Marketing
William Frederick, CFO Sec
David Ralph, Independent Director
Renee Bouche, IR Contact Officer
Daniel Weiner, Director

Simulations Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Simulations Plus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Simulations Plus without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now


Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at World Market Map. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for analysis

When running Simulations Plus price analysis, check to measure Simulations Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Simulations Plus is operating at the current time. Most of Simulations Plus' value examination focuses on studying past and present price action to predict the probability of Simulations Plus' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Simulations Plus' price. Additionally, you may evaluate how the addition of Simulations Plus to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Simulations Plus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Simulations Plus. If investors know Simulations will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Simulations Plus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
823.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Simulations Plus is measured differently than its book value, which is the value of Simulations that is recorded on the company's balance sheet. Investors also form their own opinion of Simulations Plus' value that differs from its market value or its book value, called intrinsic value, which is Simulations Plus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Simulations Plus' market value can be influenced by many factors that don't directly affect Simulations Plus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Simulations Plus' value and its price as these two are different measures arrived at by different means. Investors typically determine Simulations Plus value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Simulations Plus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.